Back
Seres Therapeutics Vs. Neurogene Industry Stock Comparison
Sell
43
MCRB
Seres Therapeutics
Last Price:
0.80
Seasonality Move:
-5.38%
Buy
75
NGNE
Neurogene
Last Price:
65.96
Seasonality Move:
58.98%
Sell
43
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $0.80. The Score for MCRB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- MCRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $0.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -1300848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.75 - 0.87) | Sell |
| Bollinger Bands (100): | (0.74 - 1.12) | Sell |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.06 | Buy |
| Relative Strength Index (14 RSI): | 75.97 | Buy |
| Chaikin Money Flow: | 176225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.28 - 53.36) | Buy |
| Bollinger Bands (100): | (34.64 - 46.72) | Buy |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Buy |
| 20-day SMA: | 0.79 | Buy |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 0.93 | Sell |
| 8-day EMA: | 0.79 | Buy |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 1.19 | Sell |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.43 | Buy |
| 20-day SMA: | 49.56 | Buy |
| 50-day SMA: | 43.32 | Buy |
| 200-day SMA: | 37.93 | Buy |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 48.54 | Buy |
| 50-day EMA: | 44.96 | Buy |
| 200-day EMA: | 36.96 | Buy |
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Seres Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||